findmyKOL
Clinical trialNCT01234935CompletedPhase 2Interventional

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

SponsorTranslational Oncology Research InternationalEnrollment8Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Central Hematology Oncology Medical Group, Inc.

    Alhambra, California, United States

  • Tori Fullerton (st. Jude Heritage Healthcare Virginia K. Crosson Cancer Center)

    Fullerton, California, United States

  • Pacific Shores Medical Group

    Long Beach, California, United States

  • Translational Oncology Research International (tori) Network

    Los Angeles, California, United States

  • Ucla Medical Center

    Los Angeles, California, United States

  • Tori Northridge (north Valley Hematology/oncology Medical Group)

    Northridge, California, United States

  • Ucla Pasadena

    Pasadena, California, United States

  • Tori Inland Valley (wilshire Oncology Medical Group, Inc. )

    Pomona, California, United States

  • Tori Redondo Beach (cancer Care Associates Medical Group, Inc.)

    Redondo Beach, California, United States

  • Tori Santa Barbara I (santa Barbara Hematology Oncology Medical Group, Inc.)

    Santa Barbara, California, United States

  • Tori Santa Barbara Ii (sansum Clinic)

    Santa Barbara, California, United States

  • Tori Santa Maria (central Coast Medical Oncology Corporation)

    Santa Maria, California, United States

  • Ucla Valencia

    Valencia, California, United States

  • Suburban Hematology-Oncology Associates, P.A.

    Lawrenceville, Georgia, United States

  • Northwest Georgia Oncology Centers, P.C.

    Marietta, Georgia, United States

  • Chevy Chase Healthcare Management, Llc

    Chevy Chase, Maryland, United States

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jan 2011
Primary completion
27 Nov 2017
Completion
27 Nov 2017
Last update posted
9 Jan 2018
Registered enrollment
8
Registry id
NCT01234935

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.